Literature DB >> 7784593

Thrombosed hemodialysis grafts: percutaneous mechanical balloon declotting versus thrombolysis.

M R Middlebrook1, M A Amygdalos, M C Soulen, Z J Haskal, R D Shlansky-Goldberg, C Cope, M J Pentecost.   

Abstract

PURPOSE: To compare a technique of mechanical balloon declotting of thrombosed hemodialysis grafts with conventional pulsed-spray thrombolysis.
MATERIALS AND METHODS: Forty patients had 53 episodes of graft thrombosis over a 19-month period. Twenty-nine grafts were randomly treated with thrombolysis with urokinase and 24 grafts with mechanical declotting by placement of crossed balloon catheters within the graft. Patency was determined by retrospective review of hemodialysis records.
RESULTS: Successful hemodialysis for 1 week after the procedure was achieved in 21 (88%) of the 24 grafts treated mechanically and 26 (90%) of 29 grafts treated with thrombolysis. Continuous pulse oximetry showed no change in oxygen saturation in either group, and no clinical signs or symptoms of pulmonary embolism were noted. Average total procedure times were 2.2 hours for mechanical declotting and 3.5 hours for thrombolysis (P < .05). Probability of patency (mechanical vs thrombolysis) was 42% vs 45% at 3 months, 36% vs 25% at 6 months, and 8% vs 4% at 12 months. One major complication of ulnar artery embolization occurred in the thrombolysis group.
CONCLUSION: Mechanical declotting of hemodialysis grafts is faster and as effective as thrombolysis.

Entities:  

Mesh:

Year:  1995        PMID: 7784593     DOI: 10.1148/radiology.196.1.7784593

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Patency and life-spans of failing hemodialysis grafts in patients undergoing repeated percutaneous de-clotting.

Authors:  A V Mansilla; B D Toombs; W K Vaughn; J I Zeledon
Journal:  Tex Heart Inst J       Date:  2001

2.  Paradoxical embolism after declotting of hemodialysis fistulae/grafts in patients with patent foramen ovale.

Authors:  Steven Wu; Iftikhar Ahmad; Sohail Qayyum; Stephan Wicky; Sanjeeva P Kalva
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-05       Impact factor: 8.237

3.  Pharmacomechanical Thrombolysis of Dialysis Access Grafts Using the MTI Castañeda Over-the-Wire Brush Catheter and Reteplase.

Authors:  Alexjandro Mendez-Castillo; Syed Hassain; Flavio Castañeda
Journal:  Semin Intervent Radiol       Date:  2004-06       Impact factor: 1.513

4.  A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion.

Authors:  R D Shlansky-Goldberg; A H Matsumoto; G A Baumbach; J B Siegel; R D Raabe; T P Murphy; C Deng; J Ray Dawkins; V J Marder
Journal:  J Thromb Haemost       Date:  2008-04-02       Impact factor: 5.824

Review 5.  Pre-emptive correction for haemodialysis arteriovenous access stenosis.

Authors:  Pietro Ravani; Robert R Quinn; Matthew J Oliver; Divya J Karsanji; Matthew T James; Jennifer M MacRae; Suetonia C Palmer; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2016-01-07

6.  Efficacy of a modified pharmacomechanical thrombolysis technique for endovascular treatment of thrombosed prosthetic arteriovenous grafts.

Authors:  Sun Young Choi; Byung Gil Choi; Kum Hyun Han; Ho Jong Chun
Journal:  Korean J Radiol       Date:  2012-04-17       Impact factor: 3.500

7.  Percutaneous treatment of failed native dialysis fistulas: use of pulse-spray pharmacomechanical thrombolysis as the primary mode of therapy.

Authors:  Sung Ki Cho; Heon Han; Sam Soo Kim; Ji Yeon Lee; Sung Wook Shin; Young Soo Do; Kwang Bo Park; Sung Wook Choo; In-Wook Choo
Journal:  Korean J Radiol       Date:  2006 Jul-Sep       Impact factor: 3.500

8.  [Percutaneous transluminal angioplasty combined with thrombolysis for acute thrombosis in arterio-venous fistula and graft].

Authors:  Shuchao Zhang; Cheng Zhu; Youxin Ye; Hua Li
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-07-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.